Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00010114 · ClinicalTrials.gov registry record

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

A clinical trial, sponsored by Pediatric Brain Tumor Consortium.

Completed
Registry status
83
Enrollment target

NCT00010114 is a clinical trial that has completed, run by Pediatric Brain Tumor Consortium. The registered enrollment target is 83 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00010114 has completed, sponsored by Pediatric Brain Tumor Consortium.

COMPLETED
Registry status
83 participants
Enrollment target

Study Summary

RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2001-03
Est. Completion 2003-03

Sponsor

Pediatric Brain Tumor Consortium

27 total trials

What the Registry Record Tells You About NCT00010114

The ClinicalTrials.gov registry entry for NCT00010114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatric Brain Tumor Consortium, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00010114 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00010114 about?

NCT00010114 is a clinical study titled "Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children". RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.

What is the current status of trial NCT00010114?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2001-03. Estimated completion is 2003-03.

Who is sponsoring clinical trial NCT00010114?

This trial is sponsored by Pediatric Brain Tumor Consortium, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.